Myo Test
- UID
- IMP/IVD/2021/000413_738dfb9a968bda14b7590712e0804dd2_87133fb9ff614aff2c703bd2148d155c
- Device class
- Class B
- Brand name
- Finecare Beta-HCG Rapid Quantitative Test
- License holder
- Star Biomed Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- The Finecare™ Myo Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare™ FIA System (Finecare Beta-HCG Rapid Quantitative Test) for quantitative determination of Myoglobin in human whole blood, serum or plasma
Myo Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000413_738dfb9a968bda14b7590712e0804dd2_87133fb9ff614aff2c703bd2148d155c. This device is marketed under the brand name Finecare Beta-HCG Rapid Quantitative Test. The license holder is Star Biomed Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.